Healthcare use · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with somatoform disorders and medically unexplained physical symptoms
Psychological therapy probably leads to lower acceptability 1 ‐ proportion of participants withdrawing during… compared with usual care or waiting list (moderate certainty).
1 finding from 1 review
Dysfunctional cognitions, emotions, or behaviours (participant rated) at end of treatment Whitely Index · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · people with somatoform disorders and medically unexplained physical symptoms
Psychological therapy may leads to higher treatment response at end of treatment CGI‐improvement/Global… compared with usual care or waiting list (low certainty).
1 finding from 1 review
Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Healthcare use · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Severity of somatic symptoms at end of treatment · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with somatoform disorders and medically unexplained physical symptoms
Psychological therapy showed no clear difference in acceptability 1 ‐ proportion of participants withdrawing during… compared with enhanced or structured care (moderate certainty).
1 finding from 1 review
Dysfunctional cognitions, emotions, or behaviours at end of treatment Whitely Index (different forms) · people with somatoform disorders and medically unexplained physical symptoms
1 finding from 1 review
Intervention not reported
fatigue (Andrographis paniculata) · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
fatigue (data tracker) · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
fatigue (Omega‐3 Fatty acids) · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
fatigue (Mediterranean diet) · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
fatigue (reflexology) · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Depression remission · adults with diabetes mellitus and depression
The intervention probably leads to higher depression remission (moderate certainty).
1 finding from 1 review
Intervention not reported
Death from any cause · adults with diabetes mellitus and depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · adults with diabetes mellitus and depression
1 finding from 1 review
Intervention not reported
Medication adherence/adverse effects · adults with diabetes mellitus and depression
1 finding from 1 review
Intervention not reported
Metabolic control (HbA1c) [%] · adults with diabetes mellitus and depression
The intervention showed no clear difference in metabolic control (HbA1c) [%] (moderate certainty).
1 finding from 1 review
Intervention not reported
Healthcare costs · adults with diabetes mellitus and depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found